University of Arizona researchers achieved nearly 90% accuracy in pancreatic cancer phenotyping using label-free optical microscopy with deep learning AI.
Key Details
- 1Label-free optical microscopy paired with deep neural networks identified tissue phenotypes at over 89% accuracy in pancreatic cancer samples.
- 2Spatial transcriptomics served as the 'ground truth' for phenotypic classification.
- 3Traditional image analysis could not match the performance of AI methods, pointing to AI's necessity in extracting meaningful features from label-free images.
- 4This approach bypasses expensive and time-intensive molecular/genetic sequencing currently used in precision medicine.
- 5The work demonstrates a significant step toward more accessible and rapid phenotyping for cancer care.
Why It Matters
This study advances the use of imaging AI in precision medicine by offering a faster, less costly method for cancer phenotyping. It highlights the potential for optical imaging and AI to broaden access to personalized care by reducing dependence on resource-heavy molecular diagnostics.
Source
EurekAlert
Related News
•EurekAlert
NIH Invests Additional $12.6M in USC-Led Imaging AI for Alzheimer's
NIH has renewed and expanded its support for a USC-led consortium developing AI to decode and treat Alzheimer's using imaging and genomic data.
•EurekAlert
USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.